Grand Canal Capital Partners
Grand Canal Capital Partners SONG DealFinder · DF-09

Fresenius SE & Co. KGaA (Helios division) — Team Review Dashboard AI-Draft Tier A Pursue v1.1

SONG Capital debt origination · DF-09 Healthcare · Hospitals · Score 50/60 · 8 May 2026
[AI-DRAFT v1.1] · Formal /60 scoring (P1) + PPLX-D Hospital deep-dive · 8 May 2026 · partner sign-off pending
Days to Fresenius 1.625% €750m 16 Jun 2027 €750m · 1.625% · ISIN XS2152329053
Counterparty
Fresenius SE & Co. KGaA
60-pt Score (FORMAL)
50 / 60
Tier A · PURSUE · P1 8 May 2026
2027 Bond Maturity
€750m
1.625% · Jan 2027 · ISIN XS2152329053 — corrected (was €1.0bn briefed)
2028 Bond Maturity
€750m + CHF 275m
0.75% EUR Feb-28 + 2.96% CHF — corrected (was €1.4bn briefed)
GCCP Fee Potential
€3–5m
1% × €300–500m senior PP
Credit Ratings
BBB / Baa3 / BBB-
S&P · Moody's · Fitch — all Stable
Helios division share
~53% rev / ~40% EBIT
DRG/SGB V tariff revenue ~85%
The Loan Opportunity · 2027–2028 Refi Wave

Fresenius parent senior PP — €300–500m 15–20yr fixed at the 2027–2028 refi window

Helios is a cashflow division, not an issuer (PPLX-D premise check confirmed). The SONG underwriting target is Fresenius SE & Co. KGaA parent, with Helios providing ~53% of group revenue and ~40% of EBIT — DRG/SGB V tariff revenue base ~85%. €13.5bn total debt, €750m 2027 + €750m 2028 EUR + CHF 275m 2028 maturity wall (corrected per fresenius.com/bonds), ND/EBITDA 2.6× (improving) inside 2.5–3.0× corridor. Praemia €702m UK hospital ground debt is the transferable comparable.
Score
50 / 60
Tier A · PURSUE
GCCP Fee (1%)
€3–5m
Base-case potential
Lane A · Go Now
2027 €1.0bn bond refi
€200–300m
15–20yr fixed PP
1.625% Jun 2027 maturity creates 270–325bp adverse reset on roll. SONG fixed-rate PP captures the spread before market reset. H1 / H2 / H8 compliant.
Lane B · Parallel
2028 €1.4bn bond refi
€200–400m
15–25yr fixed PP
Sep 2028 €1.45bn (CHF + EUR tranches) — sits inside €15bn DIP programme headroom. Multi-tranche structure naturally accommodates SONG companion.
Forward · 2029+
Schuldschein extension
€100–200m
10–15yr · Brörmann channel
Fresenius SSD repaid early Nov 2025; 2030 SSD tranche = €71m. Future SSD or PP via Hennicken / Stone treasury.
Hold · DIP only
ESG RCF
—
€2.0bn undrawn
Existing ESG RCF at parent — not a SONG slot. Monitor for utilisation.
Fee stack: Lane A €2.0–3.0m · Lane B €2.0–4.0m · combined €3–5m at 1% arrangement

Why Now — Seven Crystallising Triggers

All seven map to Fresenius / Helios-specific catalysts; partner-circulation candidates marked.
  • €750m 2027 bond at 1.625% — refi at current ~3.5–4.5% market = 270–325bp adverse reset; SONG fixed-rate PP captures spread before market reset.
  • €750m EUR + CHF 275m 2028 maturity wave (€750m 0.75% Feb 2028 + CHF 275m 2.96% 2028) — multi-tranche refi cycle creates natural PP companion slots.
  • Helios cashflow base ~85% DRG/SGB V tariff — government-backed reimbursement = MA-conditional fixed cashflow profile; transferable from Praemia €702m UK hospital ground debt precedent.
  • ND/EBITDA 2.6× Q1/26 (improving) — inside self-imposed 2.5–3.0× corridor; deleveraging momentum supportive of new long-tenor PP.
  • Sara Hennicken CFO contract extended to 2027 — stable counterparty; ex-Deutsche Bank MD with 9 years IB background; institutional fixed-income proposal naturally routed.
  • €15bn DIP programme drawn ~€8.3bn — material headroom for new bond + private placement tranches.
  • Spain Quirónsalud + Germany Helios — pan-European platform IG covenant (BBB / Baa3 / BBB- triple confirmed mid-2025).

Target Score · 60-pt Rubric

50 / 60
Tier A · PURSUE
MA Eligibility17/20
Size Fit15/15
Counterparty8/10
Operational8/8
Relationship1/5
Timing / Catalyst1/2
Estimated — not yet scored. CC Job A formal 60-pt refresh pending.

Capital Stack — Fresenius / Helios

€13.5bn total debt (Q3/25 Credit Presentation): Bonds 68% · Lease 11% · SSD 9% · Exchangeable 4% · EIB 3% · CP 1% · Other 4%. Avg cost of debt low; ND/EBITDA 2.6× Q1/26 inside 2.5–3.0× corridor. [PRIMARY · PPLX-A/B/C/D]

Maturity Wall — Fresenius / Helios

2027 €1.0bn (1.625%) · 2028 €750m EUR + CHF 275m · 2029 €500m (2.75%) + €500m (2.875%) + CHF · 2030 €71m SSD · 2031–2034 €500–1,050m/yr. [PRIMARY · PPLX-A/B/C/D]

SONG Lane Detail — Fresenius SE & Co. KGaA

Full lane economics + compliance + execution sequence. See hero above for the one-line proposition.
Lane A · 2027 €750m bond refi · Go Now
€200–300m PP · 15–20yr fixed · Jan 2027 €750m at 1.625% (XS2152329053) → 270–325bp adverse reset = SONG fixed-rate PP captures spread before market reset · H1/H2/H8 compliant.
Lane B · 2028 €750m EUR + CHF 275m parallel
€200–400m · 15–25yr fixed · Feb 2028 €750m 0.75% + CHF 275m 2.96% — sits inside €15bn DIP programme headroom (~€8.3bn drawn) · multi-tranche refi accommodates SONG companion.
Forward · Helios division Schuldschein extension
€100–200m · 10–15yr · via Hennicken / Stone treasury · DRG/SGB V tariff revenue ~85% IG-quality cashflow base · MA-conditional via German hospital portfolio precedent (MPT/Praemia €702.5m Jun 2025).
Hold · ESG RCF (DIP only)
Existing ESG RCF at parent — not a SONG slot. Monitor for utilisation.

Decision-Maker Map

Counterparty governance + IR contact roster. Verified 8 May 2026 via 13 parallel web research agents. H4 SONG-side names redacted.
1
Michael Sen — CEO
Since 1 Oct 2022 · contract extended Feb 2026 to 2031 · ex-Siemens AG MB (Healthineers IPO lead) · ex-CFO E.ON SE.
Strategic continuity through next refi cycle.
2
Sara Hennicken — CFO Primary
Since 1 Sep 2022 · contract extended to 2027 · 14yr IB / 9yr Deutsche Bank (final MD Senior Client Executive Corporate Finance) · joined Fresenius 2019 as SVP Global Treasury.
Day-to-day refi process owner · institutional fixed-income proposal naturally routed.
3
Wolfgang Kirsch — Chair Supervisory Board
Ex-CEO DZ Bank.
Cooperative-bank network access · long-tenor institutional credibility.
4
Robert Möller → Dr. Christian Pawlu — Helios MB Member
Pawlu joins Vorstand 1 Jul 2026 · COO Helios DE since Mar 2025, expanded to Helios Group incl. Quirónsalud Sep 2025 · Möller moves to Berlin/Brussels public-affairs office.
Operational continuity at division level.
P
Else Kröner-Fresenius-Stiftung (~26%)
Anchor shareholder.
Stable family-foundation owner · supportive of #FutureFresenius simplification (FMC deconsolidation Nov 2023).
IR
Nick Stone — SVP & Head of IR
nick.stone@fresenius.com · +49 6172 608-97033 · deputy Elisabeth Truckenbrodt +49 6172 608-2486.
First touch · ir-fre@fresenius.com.

Credit Metrics & Capital Structure

Total debt€13.5bn [Q3/25 Credit Pres.]
ND/EBITDA2.6× Q1/26 [Inside 2.5–3.0× corridor]
DIP Programme drawn~€8.3bn / €15bn [Headroom ~€6.7bn]
Sep 2025 issuance€1.0bn dual-tranche [€500m 2.75% Sep 2029 + €500m 3.50% Mar 2034 · LuxSE]
EIB facility€400m Sep 2025 [Hennicken / Beer · biosimilars / Kabi]
Jan 2027 maturity€750m · 1.625% [ISIN XS2152329053]
Feb 2028 maturity€750m · 0.75% + CHF 275m 2.96% [EUR + CHF tranches]
Group structureFresenius SE & Co. KGaA [Helios = ~53% rev / ~40% EBIT cashflow division]

Ratings & Peer Context

AgencyRatingOutlookDate / Notes
S&PBBBPositiveOutlook revised stable→positive 2025/early 2026
Moody'sBaa3StableAffirmed
FitchBBB-StableAffirmed
S&P timeline: outlook revised stable → positive 2025/early 2026 citing deleveraging + #FutureFresenius execution discipline. Self-imposed leverage target 2.5–3.0× ND/EBITDA. Potential BBB+ upgrade trajectory if leverage holds <2.6× = ~15–25bps spread compression.
Peer benchmark: Fresenius BBB / Baa3 mid-cap European hospital / health platform. Asklepios (unrated, shadow IG) trades at SSD ~80–120bps premium. HCA (BBB-) USD curve provides long-tenor IG hospital benchmark. MPT / Praemia REIM €702.5m German hospital portfolio refi (Jun 2025) = direct German hospital RE precedent.

BPA / MA Fit Grid

TestFit
MA-eligibility (HP / IG hospital)Strong
Fixed-only EUR (H2 / H3)Yes
Senior fixed PP productFit
H1 threshold (€200m)Pass
Counterparty IG (BBB / Baa3 / BBB-)Pass
DRG/SGB V tariff revenue ~85%Pass
Long-dated tenor (15–20yr)Pass
PRIIPs (€100k denom)Institutional
Krankenhausreform alignmentTransition

Risk Register & GCCP Dissents

RiskSeverityMitigant
Krankenhausreform (KHVVG, in force 1 Jan 2025)MedLeistungsgruppen by end-2026 · €29bn Transformation Fund 2026-2035 (50/50 federal/Länder)
DRG/SGB V tariff (Vorhaltevergütung)MedReserve-capacity payment replaces ~60% of DRG case-rate logic
Statutory health insurance (GKV) tariff disputesMedMulti-payer ~95 funds · politically exposed
REJUVENATE simplification executionMedPawlu transition Jul 2026 + portfolio review · modest discontinuity risk
Else Kröner-Fresenius-Stiftung (~26%)LowStable anchor · supportive of simplification
Helios Spain (Quirónsalud)LowStrong performer · FX-resilient EUR

GCCP Dissents & v1.2 Corrections

  • Helios is a cashflow division, not an issuer. SONG underwriting target = Fresenius SE & Co. KGaA parent. Helios provides ~53% revenue / ~40% EBIT.
  • Bond stack corrected: €750m 1.625% Jan 2027 + €750m 0.75% Feb 2028 + CHF 275m 2.96% 2028 (per fresenius.com/bonds-and-convertible-bonds) — earlier '€1bn 2027 + €1.4bn 2028' framing retired.
  • Praemia comparable is the GERMAN €702.5m hospital portfolio (Jun 2025) — directly relevant — not the UK ground debt comp originally cited.
  • CFO Hennicken contract extended to 2027 + CEO Sen extended to 2031 = stable dual-leadership through 2027–2028 refi window.

Five Execution Gates

Gate 1 — SONG pre-clearance
Anonymised · H9 compliant · Q2 2026.
Gate 2 — Internal DDQ + IR sounding
Q2 2026 · institutional fixed-income brief to Hennicken / Stone office.
Gate 3 — Joint term sheet
Q3 2026 · GCCP + SONG → CFO office.
Gate 4 — Indicative offer · 2027 anchor
Q4 2026 · ahead of Jan 2027 €750m maturity.
Gate 5 — 2028 parallel + Helios SSD extension
H1 2027 · Lane B + Forward.
Fee Projection Lane A (2027 PP): 1% × €200–300m = €2.0–3.0m
Lane B (2028 parallel): 1% × €200–400m = €2.0–4.0m
Combined: €3–5m

H-Rule Compliance Grid (H1–H13)

H1 €200m minimumPass
H2 Fixed rate onlyPass
H3 EUR fixed upliftsPass
H4 No SONG individualsOK
H5 AM firewallOK
H6 Parkdean exclusionN/A
H7 No SONG pre-clr actionOK
H8 Anti-hallucinationTiered
H9 Verify before outreachGate 1
H10 Hyperscaler self-fundN/A
H11 BESSN/A
H12 Dev 8-pt checklistN/A
H13 [AI-Draft] taggedTagged

Ask of Team

  1. Partner review — confirm score + tier + lane sequencing for Fresenius SE & Co. KGaA.
  2. Sign-off — approve outreach pathway via primary DM (see Decision-Maker Map above).
  3. Coverage — flag any conflicting intel from prior briefings; 13-target parallel web research integrated 8 May 2026.
  4. Stakes — confirm fee envelope per Row 5 fee box; risk-adjust per probability tier.
  5. Sequence — agree gate order (1→5) and timing per Row 5 execution gates.
  6. Watch — agree quarterly re-score trigger if catalyst dates slip.
Sources v1.2: Fresenius credit-relations · /bonds-and-convertible-bonds · MPT / Praemia REIM Jun 2025 (realassets.ipe.com 10131138) · Krankenhausreform (BMG) · 13 research packs 8 May 2026.

Wider DE Universe — Full Audit Roster (for future research)

All German targets identified across the SONG_DealFinder_Master research base as of 8 May 2026. Beyond the 13 in this portal, 17 additional formally scored targets + ~12 named-only entries from the country strategy pack remain. Source: 03_research/germany/ + FORMAL_SCORES_* + country_strategy_packs_Apr2026/germany/.

A · In this portal (13 targets — v1.2 dashboards live)

TargetSectorScoreTier
Fresenius / HeliosDF-09 Hospitals50A · PURSUE
VonoviaDF-12 PRS49A · PURSUE
LEG ImmobilienDF-12 PRS45A · PURSUE
AsklepiosDF-09 Hospitals43B · DEVELOP
Vantage TowersDF-16 Towers43B · DEVELOP
Mileway DEDF-15 Logistics41B · DEVELOP
Grand City PropertiesDF-12 PRS40B · WATCH
Garbe IndustrialDF-15 Logistics39B · WATCH
REWE GroupDF-07 Grocery39B · WATCH
EncavisDF-03 Renewables38B · WATCH (demoted)
EnerparcDF-03 Solar35B · WATCH
Qualitas EnergyDF-03 Renewables25C · MONITOR
Schön KlinikDF-09 Hospitals22REJECT (3 H-rule fails)

B · Formally scored Tier A · NOT yet in portal (9 PURSUE-tier targets — research priority)

Source: FORMAL_SCORES_Batch1_Apr2026.md. Scored 45-53 with [PRIMARY] tier; not yet promoted to dashboard.

TargetSectorFacilityScoreNotes
TenneT Holding DEDF-01 TSO1300+53H13 flagged for CC review · €45-50bn EMTN issuance 2026-2030 · S&P BBB+ March 2026 · Fitch BBB+ April 2026 · German federal stake 25.1% via KfW
50Hertz TransmissionDF-01 TSO1100+53Elia 80% / KfW 20% · €800m green bond Aug 2025 12yr 4.06% · €2bn debt H1 2025
Deutsche Bahn Netz AGDF-28 Rail Infra1400+53Sondervermögen anchor · German rail infrastructure
Autobahn GmbHDF-23 Toll/PPP120051State-backed availability payments · post-2020 reform
Fraport AGDF-17 Aviation105051Frankfurt airport EBITDA · cross-tagged DF-17
Munich Airport (MAG)DF-17 Aviation80050Recent refi activity
AmprionDF-01 TSO95050M31 Beteiligungs 74.9% / RWE-Apollo JV 25.1% · €25bn DIP · €2.2bn equity Dec 2025
TransnetBWDF-01 TSO70045EnBW-financed (€11.1bn outstanding + €3bn hybrid)
Digital Realty FrankfurtDF-06 DC65047Hyperscaler-adjacent (H10 sensitivity) · ringfencing analysis required

C · Formally scored Tier B/C · NOT in portal (8 targets — monitor + selective)

TargetSectorScoreTierNotes
Equinix FrankfurtDF-06 DC46BH10 hyperscaler-adjacent flag
TAG ImmobilienDF-12 PRS45A (borderline)Recent refis · eastern DE residential · BB-rated, more levered
NTT FrankfurtDF-06 DC44B[SCREENING] tier only
Patrizia AGDF-12 AM43BAM platform — not asset owner
Korian GermanyDF-09 Care43BBB- rating caps MA · NDA data room needed
HOCHTIEFDF-15 Construction42BSponsor/construction track · not asset
SANA KlinikenDF-09 Hospitals42BAOK/BKK insurer-owned · M&A tracker only
Alloheim / EMVIA LivingDF-09 Care30-34C · MONITORPE distress flagged · covenant stress

D · Country strategy pack named-only · NO formal score yet (~12 entries)

Source: 03_research/country_strategy_packs_Apr2026/germany/05_Target_Pipeline_Germany_Apr2026.md.

Target / CohortSectorAction / Status
Edeka Rhein-Ruhr · Edeka Südwest · Edeka Nord · Edeka Minden-HannoverGrocery freeholdQ3-Q4 2026 Quadoro mapping · regional cooperative entities
Deutsche Logistik REIT · VIB Vermögen · Dream Industrial Germany · ALMA / PanattoniLogisticsQ4 2026 candidate scoping
EON · Vattenfall Germany · Mainova · Stadtwerke München · Regional StadtwerkeHeating networks / DH concessionQ2 2027 mapping · 20-30yr concession tenors compatible with SONG 30yr+
EnBWUtility~€11bn outstanding + €3bn hybrid · MEGA-8 researched, not scored
Emeis Germany (post-restructuring)Care homesWatch H1 2027 · post €3.8bn restructuring · 2027 refi window possible
Engie Solutions / Dalkia German operationsHeat networksQ2 2027+ · cross-reference France pack

E · Macro research complete (pillars · not target-specific)

F · Strategic frame (carries across all DE targets)

  1. No Matching Adjustment in Germany — German life insurers use Volatility Adjustment (Solvency II Art 77d). MA-eligible appetite is UK-anchored; cross-border MA via PRA/EIOPA framework pending PPLX-G output.
  2. MEAG (Munich Re asset manager) is the central node — €12bn→€20bn infrastructure debt scaling · sole arranger track record on €450m DB Regio rolling stock + €300m Spain hybrid + Portugal Margalha solar. Approach as deal-flow partner, not pitch.
  3. AllianzGI VBL €500m mandate (Aug 2025) = scale proof for European institutional infra debt allocation.
  4. EUR/GBP hedge cost 0–15bps annualised — does not kill GBP investment economics for EUR insurers given UK rate premium ~170bps.
  5. 15–30yr senior fixed EUR bilateral = SONG innovation slot · structurally vacant in DE 2024-26 market (banks max 24yr LBBW only · public bonds max 15yr · insurer bilaterals max 15yr ERGO/Vonovia precedent).
  6. ERGO/Vonovia 15yr secured bilateral ×2 (2024) = most important structural template · same-insurer-same-structure · SONG mirrors at extended tenor.
  7. AnlV 8th Amendment (7 Feb 2025) = 5% infrastructure quota tailwind · estimated €5-10bn fresh Pensionskassen capital unlocked for infrastructure.
Provenance: Audit compiled 8 May 2026 from SONG_DealFinder_Master/03_research/germany/ (10 files including Deep Market Pack + MEGA-8) · FORMAL_SCORES_Batch1-5_Apr2026.md (22 DE-coded rows) · country_strategy_packs_Apr2026/germany/ (5 files) · 02_deal_sheets/germany/ (10 deal sheets dated Mar 2026, pre-v1.3 template, refresh pending) · bpa_market/Germany_Quadoro_Targets_Apr2026.md. Coverage Registry entry #21 Germany = DONE 2026-04. Material findings integrated to v1.2 dashboards 8 May 2026.
Grand Canal Capital Partners · SONG DealFinder · Fresenius SE & Co. KGaA
DF-05 Fossil Transition · Session 26 · 21 Apr 2026 · [AI-Draft] v1.3
Verified via Perplexity Model Council (3 models, 6 batches, 47 claims) · 21 Apr 2026 + CRO/Web governance sweep 23 Apr 2026
24 Verified · 22 Corrected · 1 Disputed · 0 Unverified · 8 primary-source overrides · Confidential — named partner sign-off required before external use